KRAS and cancer: The crosstalk between the above pathways and other tumorigenic pathways (e.g., NF-κB, KRAS–RAF–MAPK and PI3K–AKT–mTOR) have also hinted at their profoundly complex roles in cancer (Pelullo et al., 2019; Clara et al., 2020).